Bio Nordix ApS: Financial statements 2024
CVR: 35053948
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
Bio Nordix ApS (CVR 35053948) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 592,262 and a net result of DKK 67,543 compared with DKK 18,147 the year before. That is a decrease of 7.2% compared with the year before. Equity in the 2024 report amounted to DKK 445,874. The solvency ratio was 88.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 592,262
- Profit/Loss
- DKK 67,543
- Equity
- DKK 445,874
- Total Assets
- DKK 503,118
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 592K | 68K | 446K | 1 |
| 2023 | - | 638K | 18K | 378K | 1 |
| 2022 | - | 719K | 21K | 360K | 1 |
| 2021 | - | 684K | -18K | 340K | 1 |
| 2020 | - | 587K | -2K | 357K | 1 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout Bio Nordix ApS
Bio Nordix ApS was a Danish company of the type Anpartsselskab based in Hornbæk, founded in 2013. The company has been dissolved on 16 July 2026. The company was registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named ØRESUND ADVENTURES ApS and MOSV BIOPLASMA ApS. The company has 1 employee (2025). In 2025, the company reported a gross profit of DKK -6,770 and a net result of DKK -451,969 compared with DKK 67,543 the year before. Equity in the 2025 report amounted to DKK -6,095.